NCT03742336View on ClinicalTrials.gov

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

February 18, 2019

Study Completion Date

February 18, 2019

Conditions
Healthy
Interventions
DRUG

PF-04965842

Single oral 200 mg dose of PF-04965842

DRUG

Dabigatran

Single 75 mg dose of dabigatran

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03742336 - Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants | Biotech Hunter | Biotech Hunter